- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Celldex Therapeutics Inc+ Add to Watchlist
CLDX:US12.3000 USD 0.2300 1.84%
As of 20:10:00 ET on 05/23/2013.
Company Profile for Celldex Therapeutics Inc (CLDX)
Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.
Celldex Therapeutics Inc
Key Executives for Celldex Therapeutics Inc (CLDX)
|Anthony Salvatore MarucciPresident/CEO||Avery W Catlin "Chip"Senior VP/CFO/Secretary|
|Thomas DavisSenior VP/Chief Medical Ofcr||Tibor KelerSenior VP/Chief Scientific Ofcr|
|Ronald A PepinSenior VP/Chief Business Ofcr|